184 related articles for article (PubMed ID: 17500062)
1. Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties.
Christensen B; Kazanecki CC; Petersen TE; Rittling SR; Denhardt DT; Sørensen ES
J Biol Chem; 2007 Jul; 282(27):19463-72. PubMed ID: 17500062
[TBL] [Abstract][Full Text] [Related]
2. Biological role of site-specific O-glycosylation in cell adhesion activity and phosphorylation of osteopontin.
Oyama M; Kariya Y; Kariya Y; Matsumoto K; Kanno M; Yamaguchi Y; Hashimoto Y
Biochem J; 2018 May; 475(9):1583-1595. PubMed ID: 29626154
[TBL] [Abstract][Full Text] [Related]
3. Characterization of anti-osteopontin monoclonal antibodies: Binding sensitivity to post-translational modifications.
Kazanecki CC; Kowalski AJ; Ding T; Rittling SR; Denhardt DT
J Cell Biochem; 2007 Nov; 102(4):925-35. PubMed ID: 17786932
[TBL] [Abstract][Full Text] [Related]
4. Ras-transformation reduce FAM20C expression and osteopontin phosphorylation.
Schytte GN; Christensen B; Bregenov I; Sørensen ES
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830861
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin.
Hui T; Sørensen ES; Rittling SR
Matrix Biol; 2015 Jan; 41():19-25. PubMed ID: 25446551
[TBL] [Abstract][Full Text] [Related]
6. Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications.
Christensen B; Nielsen MS; Haselmann KF; Petersen TE; Sørensen ES
Biochem J; 2005 Aug; 390(Pt 1):285-92. PubMed ID: 15869464
[TBL] [Abstract][Full Text] [Related]
7. Post-translational modification and proteolytic processing of urinary osteopontin.
Christensen B; Petersen TE; Sørensen ES
Biochem J; 2008 Apr; 411(1):53-61. PubMed ID: 18072945
[TBL] [Abstract][Full Text] [Related]
8. Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 cells.
Shanmugam V; Chackalaparampil I; Kundu GC; Mukherjee AB; Mukherjee BB
Biochemistry; 1997 May; 36(19):5729-38. PubMed ID: 9153413
[TBL] [Abstract][Full Text] [Related]
9. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Minai-Tehrani A; Chang SH; Kwon JT; Hwang SK; Kim JE; Shin JY; Yu KN; Park SJ; Jiang HL; Kim JH; Hong SH; Kang B; Kim D; Chae CH; Lee KH; Beck GR; Cho MH
Cell Oncol (Dordr); 2013 Feb; 36(1):15-26. PubMed ID: 23070870
[TBL] [Abstract][Full Text] [Related]
10. Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin.
Li H; Shen H; Yan G; Zhang Y; Liu M; Fang P; Yu H; Yang P
Biochim Biophys Acta; 2015 Jun; 1854(6):581-91. PubMed ID: 25450502
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin O-glycosylation contributes to its phosphorylation and cell-adhesion properties.
Kariya Y; Kanno M; Matsumoto-Morita K; Konno M; Yamaguchi Y; Hashimoto Y
Biochem J; 2014 Oct; 463(1):93-102. PubMed ID: 25000122
[TBL] [Abstract][Full Text] [Related]
12. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
Chambers AF; Hota C; Prince CW
Cancer Res; 1993 Feb; 53(3):701-6. PubMed ID: 8425206
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry.
Keykhosravani M; Doherty-Kirby A; Zhang C; Brewer D; Goldberg HA; Hunter GK; Lajoie G
Biochemistry; 2005 May; 44(18):6990-7003. PubMed ID: 15865444
[TBL] [Abstract][Full Text] [Related]
14. C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin.
Christensen B; Kläning E; Nielsen MS; Andersen MH; Sørensen ES
J Biol Chem; 2012 Feb; 287(6):3788-97. PubMed ID: 22179617
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites.
Sørensen ES; Højrup P; Petersen TE
Protein Sci; 1995 Oct; 4(10):2040-9. PubMed ID: 8535240
[TBL] [Abstract][Full Text] [Related]
16. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.
Kazanecki CC; Uzwiak DJ; Denhardt DT
J Cell Biochem; 2007 Nov; 102(4):912-24. PubMed ID: 17910028
[TBL] [Abstract][Full Text] [Related]
17. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
18. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Behrend EI; Wilson SM; Denhardt DT
Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.
Ek-Rylander B; Andersson G
Exp Cell Res; 2010 Feb; 316(3):443-51. PubMed ID: 19854170
[TBL] [Abstract][Full Text] [Related]
20. Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro.
Zhu X; Luo C; Ferrier JM; Sodek J
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):637-43. PubMed ID: 9169595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
